1. Home
  2. TLYS vs MNOV Comparison

TLYS vs MNOV Comparison

Compare TLYS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tilly's Inc.

TLYS

Tilly's Inc.

SELL

Current Price

$4.54

Market Cap

128.1M

ML Signal

SELL

Logo Medicinova Inc

MNOV

Medicinova Inc

HOLD

Current Price

$1.54

Market Cap

137.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLYS
MNOV
Founded
1982
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.1M
137.8M
IPO Year
2011
2004

Fundamental Metrics

Financial Performance
Metric
TLYS
MNOV
Price
$4.54
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $8.25
AVG Volume (30 Days)
335.0K
★ 837.5K
Earning Date
12-02-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 62.34
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $2,360,807.00
Revenue This Year
$7.99
$78.20
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 194.15
52 Week Low
$1.14
$1.17
52 Week High
$6.25
$3.90

Technical Indicators

Market Signals
Indicator
TLYS
MNOV
Relative Strength Index (RSI) 54.83 39.71
Support Level $3.60 $1.29
Resistance Level $4.56 $1.86
Average True Range (ATR) 0.20 0.19
MACD -0.01 -0.11
Stochastic Oscillator 58.90 5.20

Price Performance

Historical Comparison
TLYS
MNOV

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley, among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

About MNOV Medicinova Inc

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.

Share on Social Networks: